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SUMMARY
The quality of premedication induced by oral
midazolam and zolpidem, a new imidazopyridine
hypnotic, was assessed in a controlled, double-
blind study in 93 patients undergoing elective
surgery under spinal or extradural anaesthesia.
The patients were allocated randomly to three
groups. Each group received the same treatment
twice at two different doses. The night before
operation, patients received zolpidem 10 mg,
midazolam 7.5 mg or placebo and, 1 h before
operation, zolpidem 20 mg, midazolam 15 mg or
placebo. The sleep inducing effects of the drugs
were comparable. Zolpidem and midazolam were
significantly more effective sedatives than
placebo 45 min after administration, but no
difference was noted between the drugs. There
was a comparable incidence of anterograde
amnesia with zolpidem and midazolam, but the
onset was shorter after zolpidem. Side effects
were comparable in the three groups. Zolpidem
is an effective hypnotic with a rapid onset and
short duration of action which may be an
alternative to midazolam for premedication.
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Premedication.
Optimal premedication for regional anaesthesia
requires both anxiolysis and sedation and the
patient's co-operation. Benzodiazepines are
administered frequently for this purpose [1] as
their anticonvulsive properties may reduce local
anaesthetic toxicity [2], although this action has
recently been questioned [3]. Recently, zolpidem,
a new imidazopyridine which acts on the central
benzodiazepine receptors, has been synthesized
[4,5]. In common with the benzodiazepines, this
new compound has anticonvulsant and muscle
relaxant properties. It also has a short elimination
half-life of 2.4 h [6]. The absence of effect on
physiological sleep [4,6,7] or memory disturb-
ance [8], may give zolpidem a theoretical ad-
vantage over the benzodiazepines in some clinical
situations such as outpatient anaesthesia.
The present study was designed to compare the
quality of premedication produced by zolpidem
and midazolam in a controlled double-blind trial.
PATIENTS AND METHODS
After Ethics Committee approval, informed con-
sent was obtained from 93 adult patients (ASA I
and II), undergoing elective minor lower limb
procedures (n = 65), varicose vein surgery (n = 8)
or inguinal hernia repair (n = 20). Surgery was
performed using subarachnoid (22- or 25-gauge
needle) or continuous extradural anaesthesia
(Tuohy 18-gauge, catheter 20-gauge). The
patients were allocated randomly to treatment
group 1 (zolpidem), 2 (midazolam) or 3 (placebo).
The three treatments were administered double-
blind. Each patient received the same drug or the
placebo twice: first, on the night before the
operation, zolpidem 10 mg, midazolam 7.5 mg or
placebo; second, in the anaesthetic room, zolpi-
dem 20 mg or midazolam 15 mg, 1 h before the
spinal or extradural anaesthesia was performed.
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Efficacy of the drugs was evaluated by the same
observer using the following criteria:
Quality of sleep during the night preceding the
operation was assessed by asking the patients: the
duration of sleep; the number of times they
awoke; the manner of wakening (spontaneous or
not); a subjective evaluation of the quality of
sleep.
Clinical assessment of premedication. Sedation,
scored: 1 = lack of sedation, patient restless; 2 =
patient awake and calm; 3 = patient asleep, not
responding to verbal stimulation but responding
to tactile stimulation; 4 = patient asleep, not
responding to verbal or to physical stimulation.
Changes in mood were assessed by the patient, with
a modified Clyde mood scale [9], which evaluates
changes in mood, concentration, alertness, ag-
gression and psychological tension [10]. Retro-
grade amnesia was assessed by asking the patient
to recall, on the day of surgery after the first
administration of the drugs, a number and a
playing card, shown during the preanaesthetic
visit. Anterograde amnesia was evaluated with the
same method, asking the patient after the second
administration of the drugs, to recall the two
items 1 min after their presentation. Amnesia was
considered complete if the patient did not re-
member either of the two items, partial if he
recalled one of them and absent if he remembered
both. On the evening after operation, anterograde
amnesia was evaluated in a different manner, by
asking the patient if he recalled the administration
of anaesthesia, transfers to the operating room, to
the recovery room and to the hospital ward.
Amnesia was considered present if the patient did
not remember any of these events. Arterial
pressure was measured with automated oscillo-
tonometry (Dinamap) and ventilatory and cardiac
frequencies clinically. Side effects, additional
analgesia or anxiolytic medication required during
the operation were noted also.
All variables were assessed during the pre-
anaesthetic visit on the day before surgery, on
arrival in the anaesthetic room before admin-
istration of drugs, every 15 min up to 1 h after
their administration and in the immediate post-
operative period. In addition, subjective evalu-
ation of the efficacy of the drugs was scored
separately by the patient and the anaesthetist on
the evening of surgery as follows: 1 = poor, 2 =
fair, 3 = good.
Patients who received additional anxiolytic or
analgesic medication during the surgical pro-
cedure were excluded from the postoperative
assessments.
Statistical analysis of qualitative variables was
performed with a Cochran-Mantel Haenszel test.
Quantitative data were subjected to analysis of
variance and the different treatments were com-
pared with a Bonferroni's test. P < 0.05 was
considered significant. All data are expressed as
mean (SEM) or median score values.
RESULTS
There were no significant differences in demo-
graphic data, ASA class, or duration of anaesthesia
and surgery between the groups (table I).
No difference was noted on the night before
surgery between the hypnotic effects of zolpidem,
midazolam and placebo; the onset of sleep was
comparable in the three groups, as were the
frequency of awakening, the patients' subjective
evaluation of the quality of sleep and the manner
of awakening (table II).
No statistical difference was observed in sed-
ation scores between the three groups, on the day
before surgery, during the preoperative visit and
TABLE I. Demographic data, anaesthetic risk, duration of anaesthesia and surgery in the three groups
(mean (SBM))
Group
Placebo
(n = 31)
Midazolam
Zolpidem
(/> = 32)
Sex
(M/F)
22/9
20/10
22/10
Age
(yr)
39(3)
46(2)
42(2)
Weight
(kg)
72(2)
69(3)
73(2)
Height
(cm)
172(1)
169 (2)
171(1)
ASA
class
(I/II)
24/7
19/11
21/11
Duration
of anaesth.
(min)
154 (14)
175 (10)
177 (10)
Duration
of surgery
(min)
81 (10)
83(7)
85(7)
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TABLE II. Clinical evaluation by patients of the quality of sleep induced by the three different pre-
medicants administered on the evening before surgery
Onset of sleep
< 15 min
< 30 min
< 60 min
> 60 min
Frequency of awakening
None or once
> once
Manner of wakening in the morning
Spontaneous
Not spontaneous
Patient's subjective evaluation
Very good or good
Fair or bad
Percentage of patients
Placebo Midazolam
40.0
26.6
3.3
30.0
51.7
48.3
66.7
33.3
71.0
29.0
26.7
53.3
10.0
10.0
76.7
23.3
73.3
26.7
90.0
10.0
in group
Zolpidem
38.7
22.5
25.8
12.9
65.6
34.4
75.0
25.0
75.0
25.0
TABLE III . Sedation scores before and after drug administration {median (range)). 1 = Lack of sedation,
restless patient; 2 = awake calm patient; 3 = asleep, not responding to verbal stimulation; 4 = asleep,
not responding to physical stimulation. * Significantly different from placebo (P < 0.05)
Group
Placebo
(n = 31)
Midazolam
(n = 30)
Zolpidem
in = 32)
visit
2
(1-2)
2
(1-2)
2
(1-2)
0
2
(1-2)
2
(1-2)
2
(1-2)
Time after
15
2
(2-3)
2
(2-3)
2
(1-3)
premedication (min)
30
2
(2-3)
2
(2-4)
2
(1-4)
45
2
(2-3)
2.5*
(2-1)
3*
(2-1)
60
2
(2-3)
3*
(2-4)
3*
(2-4)
7
After
op.
2
(1-2)
2
(2-3)
2
(1-3)
before the administration of the drugs. Forty-five zolpidem group and 38 % of the patients in the
minutes after administration, zolpidem and mida- midazolam group still had partial or total antero-
zolam were significantly more sedative than grade amnesia, compared with 6 % in the placebo
placebo, but no difference was noted between the group {P = 0.005). The incidence of partial or
drugs (table III). In the immediate postoperative total anterograde amnesia produced by the two
period (140 min after drug administration) the drugs and the placebo was similar in the im-
three groups were comparable, more than 90 % of mediate postoperative period. On the evening
the patients being considered " calm and awake" after operation, 71% of the patients in the
(score = 2). midazolam group, 80% of the patients in the
No retrograde amnesia was observed in any zolpidem group and 100% in the placebo group
patient. Figure 1 illustrates the results for antero- recalled administration of anaesthesia,
grade amnesia. Fifteen minutes after adminis- All patients remembered being transferred to
tration of the drugs, the three groups were the operating room, to the recovery room and to
comparable. Thirty minutes after administration the hospital ward.
of zolpidem, partial or total anterograde amnesia Most of the items on the Clyde mood scale
was found in significantly more patients compared (aggression, well being and psychological tension)
with the midazolam and placebo groups. At were not modified and were comparable in the
45 min, partial or total anterograde amnesia was three groups, during the whole investigation,
found in 50 % of the zolpidem and midazolam However, 60 min after administration of zol-
patients, but in only 7 % of the placebo group (P pidem, alertness and concentration were reduced
= 0.002). At 60 min, 40% of the patients in the significantly compared with midazolam and pla-
SEDATION WITH ZOLPIDEM AND PLACEBO 673
cebo, but were comparable in the three groups on
the day preceding operation and on the day of
surgery before the drugs were administered (table
IV). In the immediate postoperative period
(140 min after drug administration), alertness and
concentration scores returned to baseline values
and were comparable in the three groups. Heart
rate, mean arterial pressure and ventilatory fre-
quency remained unchanged throughout the
study period.
A similar number of patients (20 % in the active
groups and 30 % in the placebo group), required
additional anxiolytic or analgesic medication dur-
ing the surgical procedure, and were excluded
from postoperative assessment.
The incidence of the side effects was com-
parable in the three groups. Confusional be-
haviour was observed in two patients in the
zolpidem group, euphoria in one patient and
conjunctival injection in the other. In the midaz-
olam group, dysarthria was noted in one patient
and conjunctival injection in another. In the
placebo group, one patient complained of a
100-1
90-
80-
70-
6 0 -
30-
20 -
10-
• * *
* *
0 15 30 45 60 140
Time (min)
FIG. 1. Percentage of patients with anterograde amnesia after
administration of zolpidem ( • ) , midazolam ( 0 ) or placebo
( • ) • * Significantly different from placebo (P < 0.05).
cutaneous flush, a second showed confusional
behaviour and a third moderate hypotension and
bradycardia. All side effects were of minor
importance and did not last more than 2 h after
administration of the drugs.
The quality of premedication was better with
the two active drugs, as it was qualified "good"
by 60 % of the patients in the zolpidem group,
79% in the midazolam group and 38% in the
placebo group (P = 0.01). The anaesthetist con-
sidered premedication excellent in 52% of the
patients with zolpidem, in 67% with midazolam
but in only 24 % with placebo (P = 0.005).
DISCUSSION
The purpose of the study was to compare the
sedative, anxiolytic and amnesic effects of oral
zolpidem and midazolam in a controlled, double-
blind manner. Our results indicated that both
zolpidem and midazolam induced comparable
preoperative sedation and anterograde amnesia,
while psychological tension was improved signifi-
cantly after zolpidem when compared with mid-
azolam.
When compared with placebo, zolpidem and
midazolam produced significant and comparable
sedation 45 min after administration, confirming
their rapid onset of action. Patient co-operation
was not impaired by any of the drugs. After
operation, 140 min after administration of the
drugs, mean sedation scores in all groups returned
to baseline values, confirming their short duration
of action. However, a previous study using the
same doses [11] found a residual sedative effect
for up to 240 min after drug administration. This
difference may be explained by the fact that all the
patients in our study were evaluated after regional
anaesthesia, while general anaesthesia was used in
the other study.
Anxiolysis is a subjective phenomenon which is
TABLE IV. Alertness and concentration scores before and 60 min after drug administration {Clyde Mood
Scale) {mean {SBM)). * Significantly different from placebo (P < 0.05). Maximum score = 16
Concentration Alertness
Group Before After Before After
Placebo
(n = 31)
Midazolam
(» = 30)
Zolpidem
{n = 32)
14.3 (0.5) 13.9 (0.6)
15.0 (0.3) 13.4 (0.5)
14.8 (0.3) 12.2 (0.5)*
10.6 (0.4) 9.8 (0.6)
10.7 (0.4) 8.9 (0.6)
10.8 (0.4) 8.1 (0.6)*
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difficult to define and evaluate. Patient rather than
observer assessment was thought to be a more
valid indicator of anxiolysis, as it reduces observer
error in distinguishing between drowsiness and
anxiolysis. The Clyde mood scale was chosen to
provide a more precise evaluation of psychological
tension. The degree of psychological tension was
comparable between the groups on the night
preceding the operation and before receiving
premedicant drugs on the day of surgery. This
suggests that the more extensive preoperative
explanation given to the patient because of the
design of the study may have contributed to the
decreased anxiety. However, the patient's con-
centration and alertness were reduced 60 min
after administration of zolpidem, suggesting that
it was more effective than midazolam and placebo
in decreasing psychological tension, even though
the patient's anxiety level was low.
Animal studies have suggested that zolpidem
does not affect memory [8], although a study in
man reported that zolpidem produced anterograde
amnesia in a dose-related fashion [11]. These
findings are confirmed by our data, as zolpidem
20 mg produced a duration of anterograde amnesia
similar to that obtained with midazolam 15 mg
[12], but with a significantly shorter onset time.
The main aim of premedication for regional
anaesthesia is to relieve patient anxiety while
maintaining co-operation. The preanaesthetic
visit alone is effective in reducing patient ap-
prehension [13], but this may not remove the need
for medication. Our results demonstrated that,
after a preanaesthetic visit where a good re-
lationship was established between the patient
and the physician, placebo was as effective as
zolpidem 10 mg and midazolam 7.5 mg in
decreasing anxiety the night before surgery.
In a previous study [7], there were no residual
effects 9 h after administration of zolpidem 10, 20
and 30 mg, assessed by digit-symbol substitution
and a complex reaction time task. Our study
confirmed these findings, as all the variables
assessed returned to baseline values on the
evening following administration of the drug.
No significant side effects were seen after
zolpidem or midazolam. However, paradoxical
reactions have been described occasionally fol-
lowing administration of benzodiazepines [14].
None occurred in our study after administration
of either active compound, but the number of
patients was too small to draw any definite
conclusion.
In conclusion, zolpidem is a new hypnotic
agent with a rapid onset and a short duration of
action which may be an alternative premedicant to
midazolam for regional anaesthesia, when sed-
ation, anxiolysis and anterograde amnesia are
desired.
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